Macrophage miR-34a Is a Key Regulator of Cholesterol Efflux and Atherosclerosis

Ross, 1999, Atherosclerosis—an inflammatory disease, N. Engl. J. Med., 340, 115, 10.1056/NEJM199901143400207 Lusis, 2000, Atherosclerosis, Nature, 407, 233, 10.1038/35025203 Ye, 2011, ATP-binding cassette transporters A1 and G1, HDL metabolism, cholesterol efflux, and inflammation: important targets for the treatment of atherosclerosis, Curr. Drug Targets, 12, 647, 10.2174/138945011795378522 Yvan-Charvet, 2010, Role of HDL, ABCA1, and ABCG1 transporters in cholesterol efflux and immune responses, Arterioscler. Thromb. Vasc. Biol., 30, 139, 10.1161/ATVBAHA.108.179283 Peled, 2014, Dynamic Aspects of Macrophage Polarization during Atherosclerosis Progression and Regression, Front. Immunol., 5, 579, 10.3389/fimmu.2014.00579 Xu, 2015, A metabolic stress-inducible miR-34a-HNF4α pathway regulates lipid and lipoprotein metabolism, Nat. Commun., 6, 7466, 10.1038/ncomms8466 Fu, 2012, Aberrantly elevated microRNA-34a in obesity attenuates hepatic responses to FGF19 by targeting a membrane coreceptor β-Klotho, Proc. Natl. Acad. Sci. USA, 109, 16137, 10.1073/pnas.1205951109 Fu, 2014, MicroRNA 34a inhibits beige and brown fat formation in obesity in part by suppressing adipocyte fibroblast growth factor 21 signaling and SIRT1 function, Mol. Cell. Biol., 34, 4130, 10.1128/MCB.00596-14 Pan, 2019, Adipocyte-secreted exosomal microRNA-34a inhibits M2 macrophage polarization to promote obesity-induced adipose inflammation, J. Clin. Invest., 129, 834, 10.1172/JCI123069 Badi, 2018, miR-34a Promotes Vascular Smooth Muscle Cell Calcification by Downregulating SIRT1 (Sirtuin 1) and Axl (AXL Receptor Tyrosine Kinase), Arterioscler. Thromb. Vasc. Biol., 38, 2079, 10.1161/ATVBAHA.118.311298 Badi, 2015, MicroRNA-34a Induces Vascular Smooth Muscle Cells Senescence by SIRT1 Downregulation and Promotes the Expression of Age-Associated Pro-inflammatory Secretory Factors, J. Gerontol. A Biol. Sci. Med. Sci., 70, 1304, 10.1093/gerona/glu180 Ito, 2010, MicroRNA-34a regulation of endothelial senescence, Biochem. Biophys. Res. Commun., 398, 735, 10.1016/j.bbrc.2010.07.012 Su, 2018, Downregulation of miR-34a promotes endothelial cell growth and suppresses apoptosis in atherosclerosis by regulating Bcl-2, Heart Vessels, 33, 1185, 10.1007/s00380-018-1169-6 Calkin, 2010, Liver x receptor signaling pathways and atherosclerosis, Arterioscler. Thromb. Vasc. Biol., 30, 1513, 10.1161/ATVBAHA.109.191197 Liao, 2011, Krüppel-like factor 4 regulates macrophage polarization, J. Clin. Invest., 121, 2736, 10.1172/JCI45444 Li, 2012, Bile Acid signaling in liver metabolism and diseases, J. Lipids, 2012, 754067 Wittenburg, 2002, Biliary cholesterol secretion by the twinned sterol half-transporters ABCG5 and ABCG8, J. Clin. Invest., 110, 605, 10.1172/JCI0216548 Albrecht, 2004, ABCA1 expression in carotid atherosclerotic plaques, Stroke, 35, 2801, 10.1161/01.STR.0000147036.07307.93 Tavoosi, 2015, Cholesterol Transporters ABCA1 and ABCG1 Gene Expression in Peripheral Blood Mononuclear Cells in Patients with Metabolic Syndrome, Cholesterol, 2015, 682904, 10.1155/2015/682904 Rayner, 2010, MiR-33 contributes to the regulation of cholesterol homeostasis, Science, 328, 1570, 10.1126/science.1189862 Repa, 2000, Regulation of mouse sterol regulatory element-binding protein-1c gene (SREBP-1c) by oxysterol receptors, LXRalpha and LXRbeta, Genes Dev., 14, 2819, 10.1101/gad.844900 Schultz, 2000, Role of LXRs in control of lipogenesis, Genes Dev., 14, 2831, 10.1101/gad.850400 Näär, 2018, miR-33: a metabolic conundrum, Trends Endocrinol. Metab., 29, 667, 10.1016/j.tem.2018.04.004 Joseph, 2003, Reciprocal regulation of inflammation and lipid metabolism by liver X receptors, Nat. Med., 9, 213, 10.1038/nm820 Zhang, 2005, Hepatic expression of scavenger receptor class B type I (SR-BI) is a positive regulator of macrophage reverse cholesterol transport in vivo, J. Clin. Invest., 115, 2870, 10.1172/JCI25327 Chevre, 2018, Therapeutic modulation of the bile acid pool by Cyp8b1 knockdown protects against nonalcoholic fatty liver disease in mice, FASEB J., 32, 3792, 10.1096/fj.201701084RR Patankar, 2018, Genetic ablation of Cyp8b1 preserves host metabolic function by repressing steatohepatitis and altering gut microbiota composition, Am. J. Physiol. Endocrinol. Metab., 314, E418, 10.1152/ajpendo.00172.2017 Bertaggia, 2017, Cyp8b1 ablation prevents Western diet-induced weight gain and hepatic steatosis because of impaired fat absorption, Am. J. Physiol. Endocrinol. Metab., 313, E121, 10.1152/ajpendo.00409.2016 Kaur, 2015, Loss of Cyp8b1 improves glucose homeostasis by increasing GLP-1, Diabetes, 64, 1168, 10.2337/db14-0716 Slätis, 2010, Abolished synthesis of cholic acid reduces atherosclerotic development in apolipoprotein E knockout mice, J. Lipid Res., 51, 3289, 10.1194/jlr.M009308 Schwarz, 2001, Alternate pathways of bile acid synthesis in the cholesterol 7alpha-hydroxylase knockout mouse are not upregulated by either cholesterol or cholestyramine feeding, J. Lipid Res., 42, 1594, 10.1016/S0022-2275(20)32213-6 Post, 2004, Cholesterol 7alpha-hydroxylase deficiency in mice on an APOE*3-Leiden background impairs very-low-density lipoprotein production, Arterioscler. Thromb. Vasc. Biol., 24, 768, 10.1161/01.ATV.0000121572.21122.59 Zhou, 2018, Nonalcoholic fatty liver disease contributes to subclinical atherosclerosis: A systematic review and meta-analysis, Hepatol Commun, 2, 376, 10.1002/hep4.1155 Madan, 2015, Nonalcoholic fatty liver disease and carotid artery atherosclerosis in children and adults: a meta-analysis, Eur. J. Gastroenterol. Hepatol., 27, 1237, 10.1097/MEG.0000000000000429 Du, 2014, MicroRNA-155 deficiency results in decreased macrophage inflammation and attenuated atherogenesis in apolipoprotein E-deficient mice, Arterioscler. Thromb. Vasc. Biol., 34, 759, 10.1161/ATVBAHA.113.302701 Huang, 2019, TRIM14 promotes endothelial activation via activating NF-κB signaling pathway, J. Mol. Cell Biol., 2019, mjz040 Turley, 1994, Reevaluation and application of the dual-isotope plasma ratio method for the measurement of intestinal cholesterol absorption in the hamster, J. Lipid Res., 35, 328, 10.1016/S0022-2275(20)41221-0 Zhang, 2012, Loss of FXR protects against diet-induced obesity and accelerates liver carcinogenesis in ob/ob mice, Mol. Endocrinol., 26, 272, 10.1210/me.2011-1157 Naik, 2006, Pharmacological activation of liver X receptors promotes reverse cholesterol transport in vivo, Circulation, 113, 90, 10.1161/CIRCULATIONAHA.105.560177 Xu, 2016, Farnesoid X receptor activation increases reverse cholesterol transport by modulating bile acid composition and cholesterol absorption in mice, Hepatology, 64, 1072, 10.1002/hep.28712 Zhang, 2006, FXR deficiency causes reduced atherosclerosis in Ldlr-/- mice, Arterioscler. Thromb. Vasc. Biol., 26, 2316, 10.1161/01.ATV.0000235697.35431.05